Background C-reactive protein (CRP) is an inflammatory marker of great significance for
progression and prognosis of diffuse large B-cell lymphoma (DLBCL). However, previous …

Background The development of diffuse large B-cell lymphoma (DLBCL), a prevalent
subgroup of non-Hodgkin lymphoma (NHL), potentially involves various cytokines. We …

Background Many studies have explored the relationship between C-reactive protein (CRP)
levels and survival outcomes in patients with ovarian cancer (OC); however, consistent …

The prognostic value of the geriatric nutritional risk index (GNRI) is not clear in patients with
diffuse large B-cell lymphoma (DLBCL). This study was designed to analyze the GNRI in …

This study aims to investigate whether neutrophil to lymphocyte ratio (NLR) is an
independent predictor in newly diagnosed diffuse large B-cell lymphoma (DLBCL) patients …

BACKGROUND: The prognostic value of geriatric nutritional risk index (GNRI) for diffuse
large B-cell lymphoma (DLBCL) treated in the rituximab era was not clear. OBJECTIVE: To …

Objective Primary adrenal lymphoma (PAL) is a rare form of adrenal mass. We summarize
our experience in its clinical presentation, biochemical indexes, radiological features …

Although immunotherapy is a potential strategy to resist cancers, due to the inadequate
acknowledge, this treatment is not always effective for diffuse large B cell lymphoma …

The current meta-analysis was conducted aiming to explore the association between pre-
therapy CRP and DLBCL survival outcomes. We retrieved previously published studies …

Clinical characteristics of angioimmunoblastic T-cell lympho... : Medicine Clinical
characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as …